|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
61,413,000 |
Market
Cap: |
7.64(B) |
Last
Volume: |
676,860 |
Avg
Vol: |
553,852 |
52
Week Range: |
$108.89 - $174.24 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : 5.4 |
Insider 3/6 Months : 6 |
|
Guru Rank Number : 773 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Repligen is a life sciences company that develops and commercializes bioprocessing technologies and systems used in the process of manufacturing biological drugs. Co.'s bioprocessing business is comprised of:Filtration, which includes XCell Alternating Tangential Flow systems that are used in upstream perfusion cell culture processing; Chromatography, which includes products used in downstream purification, development, manufacturing and quality control of biological drugs; Process Analytics, which complements and supports its Filtration, Chromatography and Proteins franchises; and Proteins, which are represented by its Protein A affinity ligands and cell culture growth factor products.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
250 |
250 |
5,065 |
Total Buy Value |
$0 |
$37,673 |
$37,673 |
$638,149 |
Total People Bought |
0 |
1 |
1 |
4 |
Total Buy Transactions |
0 |
1 |
1 |
4 |
Total Shares Sold |
26,447 |
53,203 |
111,253 |
161,560 |
Total Sell Value |
$3,271,688 |
$7,352,351 |
$15,843,450 |
$24,963,268 |
Total People Sold |
1 |
1 |
2 |
5 |
Total Sell Transactions |
1 |
2 |
6 |
13 |
End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Barthelemy Nicholas |
|
|
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
973 |
4,441 |
|
- |
|
Konstantinov Konstantin |
|
|
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
973 |
2,894 |
|
- |
|
Mhatre Rohin |
|
|
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
973 |
4,019 |
|
- |
|
Pax Margaret |
|
|
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
973 |
2,016 |
|
- |
|
Madaus Martin D |
|
|
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
973 |
5,586 |
|
- |
|
Eglinton Manner Carrie |
|
|
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
973 |
4,466 |
|
- |
|
Muir Glenn P |
|
|
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
973 |
33,256 |
|
- |
|
Dawes Karen A |
|
|
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
973 |
92,096 |
|
- |
|
Hunt Anthony |
|
|
2025-05-15 |
4 |
AS |
$122.66 |
$3,271,688 |
D/D |
(26,447) |
109,854 |
|
0% |
|
Bylund James |
Chief Operating Officer |
|
2025-04-01 |
4 |
D |
$128.50 |
$58,339 |
D/D |
(454) |
23,711 |
|
- |
|
Hunt Anthony |
|
|
2025-03-17 |
4 |
AS |
$148.05 |
$4,080,663 |
D/D |
(26,756) |
136,301 |
|
-19% |
|
Hunt Anthony |
|
|
2025-03-17 |
4 |
OE |
$33.87 |
$1,464,267 |
D/D |
26,756 |
163,057 |
|
- |
|
Pax Margaret |
|
|
2025-03-17 |
4 |
B |
$150.69 |
$37,673 |
D/D |
250 |
1,043 |
0.01 |
-19% |
|
Bylund James |
Chief Operating Officer |
|
2025-03-13 |
4 |
D |
$142.44 |
$24,927 |
D/D |
(175) |
24,165 |
|
- |
|
Bylund James |
Chief Operating Officer |
|
2025-03-13 |
4 |
A |
$0.00 |
$0 |
D/D |
381 |
24,340 |
|
- |
|
Bylund James |
Chief Operating Officer |
|
2025-03-03 |
4 |
D |
$155.38 |
$192,516 |
D/D |
(1,239) |
23,959 |
|
- |
|
Bylund James |
Chief Operating Officer |
|
2025-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
6,435 |
25,198 |
|
- |
|
Garland Jason K |
CFO |
|
2025-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
6,435 |
13,795 |
|
- |
|
Kuriyel Ralf |
Senior VP, R&D |
|
2025-03-03 |
4 |
D |
$155.38 |
$59,977 |
D/D |
(386) |
16,062 |
|
- |
|
Kuriyel Ralf |
Senior VP, R&D |
|
2025-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
4,826 |
16,448 |
|
- |
|
Loeillot Olivier |
Chief Executive Officer |
|
2025-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
14,480 |
46,693 |
|
- |
|
Hunt Anthony |
|
|
2025-03-03 |
4 |
D |
$155.38 |
$1,575,864 |
D/D |
(10,142) |
136,301 |
|
- |
|
Loeillot Olivier |
Chief Executive Officer |
|
2025-02-27 |
4 |
D |
$156.54 |
$53,693 |
D/D |
(343) |
32,213 |
|
- |
|
Kuriyel Ralf |
Senior VP, R&D |
|
2025-02-27 |
4 |
D |
$156.54 |
$61,207 |
D/D |
(391) |
11,622 |
|
- |
|
Bylund James |
Chief Operating Officer |
|
2025-02-27 |
4 |
D |
$156.54 |
$201,154 |
D/D |
(1,285) |
18,763 |
|
- |
|
461 Records found
|
|
Page 1 of 19 |
|
|